Indefinite Delivery Contract SPE8EQ17D5001

This Blanket Purchase Agreement is a single-award contract issued by the Defense Health Agency to procure reagents for a Beckman Coulter hematology analyzer located at the MEDDAC-Japan laboratory. The potential value of the contract is $250,000. Orders may be placed through June 30, 2026 for the purchase of reagents to support the named Beckman Coulter DXH800 analyzer with serial number AY19253. The prime contractor is Beckman Coulter K.K., a subsidiary of Danaher Corporation. As a medical...

The U.S. Department of the Navy's Bureau of Medicine and Surgery has awarded a single-award, indefinite delivery contract (IDC) to Microgenics Corporation's Clinical Diagnostics Division for the procurement of MDMA/MDA reagent kits. The $1,154,822.40 contract has a performance period from March 2024 to March 2029. This IDC will provide the Department of Defense Drug Demand Reduction Program with a variety of immunoassay reagent test kits and related laboratory supplies to support substance abuse...

Microgenics Corporation, a division of Thermo Electron Corporation's Clinical Diagnostics business, has been awarded multiple firm fixed price delivery orders under an Indefinite Delivery Contract (IDC) by the Department of the Navy Bureau of Medicine and Surgery. The delivery orders, valued from $4,013 to $34,913.10, are for the provision of DRI-ECSTASY PLUS MDMA/MDA and other reagent kits to support the Bureau's drug testing and identification programs at Navy and Marine Corps medical...

Microgenics Corporation, a subsidiary of Thermo Electron Corporation, was awarded a single-award Indefinite Delivery Contract (IDC) by the Department of the Navy Bureau of Medicine and Surgery for the supply of DRI opiate reagent test kits in support of the DOD Drug Demand Reduction Program. The $750,435.30 IDC has a ceiling value and allows for the issuance of firm-fixed price delivery orders over a 5-year period of performance through May 2028. Microgenics has received multiple task orders...

The Department of Veterans Affairs (VA), through its Veterans Integrated Service Network 1 (VISN 1), has awarded a Blanket Purchase Agreement (BPA) to Microgenics Corporation, a subsidiary of Thermo Electron Corporation. The BPA, valued at a ceiling of $450,000.00, is for the provision of toxicology reagents and equipment, including immunoassay reagent test kits, drug screening products, and related laboratory supplies to support substance abuse testing and treatment programs at military medical...

The Department of the Army Medical Command awarded a $1 million blanket purchase agreement to Pharmalucence, Inc. to provide various radiopharmaceuticals to military treatment facilities. No set-aside was designated for this single award contract, which has a period of performance from October 1, 2020 through September 30, 2025. Three task orders were subsequently awarded against this blanket purchase agreement by the Defense Health Agency to procure radiopharmaceuticals and related supplies...

The Department of the Navy Bureau of Medicine and Surgery (BUMED) awarded an Indefinite Delivery Contract (IDC) valued at $825,606.25 to Siemens Healthcare Diagnostics Inc., a subsidiary of Siemens Aktiengesellschaft, to provide amphetamine (AMP) and methamphetamine (METH) reagent kits and associated laboratory diagnostic equipment and services. The contract was awarded on June 17, 2019 without any set-aside designations. Under the IDC, Siemens Healthcare Diagnostics has received multiple firm...

The U.S. Department of the Army Medical Command awarded a Blanket Purchase Agreement (BPA) contract, identified as W912CN23A0004, to Tecan SP, Inc., a small business manufacturer, to supply Column Cerex THC 3mL 35mg test kits. The BPA has a ceiling value of $250,000 and will run through July 4, 2026, allowing the Army to efficiently order these specialized forensic toxicology supplies as needed. Tecan SP, Inc. received two firm-fixed-price call orders under this BPA, valued at $54,055 each,...

Roche Diagnostics Corporation has been awarded a single award blanket purchase agreement by the Defense Health Agency to provide laboratory testing reagents and a cell stainer. The potential value of the BPA is $129,021.70 through April 2024. A firm fixed price call was placed against the BPA for $15,314.77 to supply reagents supporting DHA programs. The reagents will be delivered to a facility in Castleton, Indiana with performance through September 2023. As the prime contractor, Roche...

This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The 5-year, single-award contract has a ceiling value of $303,372.63 and does not use any set-aside designations. Through this BPA, the VA can acquire essential medical equipment, reagents, and...